Litcius/Paper detail

The inflammatory profile of exacerbations in patients with severe refractory eosinophilic asthma receiving mepolizumab (the MEX study): a prospective observational study

P. Jane McDowell, Sarah Diver, Freda Yang, Catherine Borg, John Busby, Vanessa Brown, Rahul Shrimanker, Ciara Cox, Christopher E. Brightling, Rekha Chaudhuri, Ian Pavord, Liam G. Heaney, P. Jane McDowell, Sarah Diver, Freda Yang, Catherine Borg, John Busby, Vanessa Brown, Rahul Shrimanker, Ciara Cox, Christopher E. Brightling, Rekha Chaudhuri, Ian Pavord, Liam G. Heaney, Christopher M. Wise, Christine McAnally, Stephen Drain, Vijay Mistry, H. Arnold, Claudia Micieli, William Monterio, Marc Jones, Hattie Ellis, Samantha Thulborn, Linda Cheyne, Esther Ramsey, Sarah Howes, Michelle Bourne, Tracy Thorton, Sarah Edwards, Helen Evans, Steven G. Smith, Tracyanne Grandison

2021The Lancet Respiratory Medicine111 citationsDOI

Topics & Concepts

MepolizumabMedicineExacerbationAsthmaInternal medicineAsthma exacerbationsProspective cohort studyObservational studyPhysical therapyPediatricsEosinophilAsthma and respiratory diseasesDelphi Technique in ResearchChronic Obstructive Pulmonary Disease (COPD) Research